Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 1823 (LINC01823) is a human gene that produces a long non-coding RNA molecule longer than 200 nucleotides, transcribed from an intergenic genomic region that does not overlap annotated protein-coding genes. LINC01823 is annotated and catalogued in major genomic databases but is as yet functionally uncharacterized. Other lincRNAs function in gene regulation, chromatin remodeling, RNA stabilization, and enhancer-associated activities, often exhibiting tissue specificity, but specific biological activities and disease associations for LINC01823 are presently unknown[1][3].LINC01823 is distinct from protein-coding genes and does not encode a receptor, enzyme, or similar molecular target. It belongs in the class of long intergenic non-coding RNAs, molecules that modulate biological processes, often related to gene regulation but generally not as direct drug targets. Most lincRNAs, including LINC01823, await functional characterization, and structured data regarding its physiology, pathology, or drug interactions are currently lacking[1][3][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 1823 (LINC01823).